Lithium-Associated Psoriasis and Omega-3 Fatty Acids
Ms. A was a woman of 59 years of age with bipolar II disorder, who had been taking lithium for 6 years. After 2 years of lithium treatment, she developed psoriasis on her head, arms, legs, belly, and nails in the form of skin eruptions and scales. In addition to treatment with lithium, carbamazepine, lorazepam, and levothyroxine, she began taking double-blind-study medication because of depression. Initially, she received placebo for 4 months. Because she had not recovered, she was then offered open-label treatment with 6 g/day of omega-3 fatty acids for 4 months, which had no effect on her depression.After Ms. A started treatment with omega-3 fatty acids, her psoriasis disappeared completely within 4 weeks. When she stopped the medication, the skin problems returned within a week. After another 3 months, she tried another formulation of omega-3 fatty acids from a local drugstore, and it also contained EPA. She took 2 g/day for 4 months but received no positive effects.Mr. B was a man of 52 years of age with bipolar I disorder. Since his youth, he had also had psoriasis, which had become aggravated, with eruptions on his eyebrows, forehead, and elbows, after he had started taking lithium 13 years ago. In addition to lithium and levothyroxine, he blindly received omega-3 fatty acids because of recurrent depression. Because of adverse effects (diarrhea and nausea), he took varying doses of omega-3 fatty acids, between 2 and 6 g/day, which had no effect on his depression. After the double-blind phase, Mr. B continued treatment with open-label omega-3 fatty acids, at an average dose of 4 g/day, but he stopped taking it after another 2 months because his depression did not improve and he experienced the same adverse effects.Within 3 weeks after the start of treatment with omega-3 fatty acids, Mr. B recovered totally from his psoriasis. His reddish, scaly skin was transformed. After discontinuing the omega-3 fatty acids, his skin remained stable for 3 months, but then his psoriasis gradually returned.
References
Information & Authors
Information
Published In
History
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).